Compare ACXP & SLNH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACXP | SLNH |
|---|---|---|
| Founded | 2017 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 184.6M |
| IPO Year | 2021 | 2005 |
| Metric | ACXP | SLNH |
|---|---|---|
| Price | $1.44 | $1.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $95.50 | $5.00 |
| AVG Volume (30 Days) | 158.9K | ★ 9.7M |
| Earning Date | 05-12-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.41 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $38,021,000.00 |
| Revenue This Year | N/A | $55.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 80.49 |
| 52 Week Low | $1.31 | $0.42 |
| 52 Week High | $8.34 | $5.14 |
| Indicator | ACXP | SLNH |
|---|---|---|
| Relative Strength Index (RSI) | 44.44 | 44.54 |
| Support Level | $1.36 | $1.07 |
| Resistance Level | $1.79 | $1.40 |
| Average True Range (ATR) | 0.14 | 0.11 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 16.76 | 27.14 |
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
Soluna Holdings Inc is a U.S.-based company engaged in the development and operation of data centers powered by renewable energy. The company utilizes excess or curtailed energy from renewable sources to support high-performance computing applications, including cryptocurrency mining, artificial intelligence, and machine learning. Its business model focuses on converting underutilized renewable energy into computing resources through co-located data center infrastructure.